These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4958979)

  • 21. Immunochemical studies of oral fusobacteria. 5. Serological characterization of a group reactive antigen.
    Kristoffersen T
    Acta Pathol Microbiol Scand; 1969; 77(4):707-16. PubMed ID: 4986614
    [No Abstract]   [Full Text] [Related]  

  • 22. [Difficulties in the interpretation of serologic studies of the blood and amniotic fluid in a case with suspected Rh incompatibility].
    Gajewska E; Woytoń J
    Pol Tyg Lek; 1970 Oct; 25(41):1546-7. PubMed ID: 4991011
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-idiotypes of human origin].
    Ropartz C; Rivat L; Rivat C; Brazier D
    Nouv Rev Fr Hematol; 1970; 10(3):363-9. PubMed ID: 4247941
    [No Abstract]   [Full Text] [Related]  

  • 24. The prevention of Rh-haemolytic disease.
    Clarke CA
    Sci Basis Med Annu Rev; 1968; ():168-85. PubMed ID: 4970016
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin.
    Henney CS; Ishizaka K
    J Immunol; 1968 Nov; 101(5):896-904. PubMed ID: 4972233
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibility of predicting wound suppuration based on data on the content of the antiglobulin factor, pepsin agglutinator].
    Kalashnik AF; Kul'berg AIa; Bartova LM
    Ortop Travmatol Protez; 1980 Nov; (11):9-11. PubMed ID: 6782534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Procedure in a case of blood incompatibility with Rh specificity].
    Stockmann J
    Ther Umsch; 1971 Jul; 28(7):444-51. PubMed ID: 4999601
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of hemolytic disease in newborns caused by antiagglutinins E (RH)].
    Argirov A; Mikhova M
    Vopr Okhr Materin Det; 1968 Oct; 13(10):71-2. PubMed ID: 4976398
    [No Abstract]   [Full Text] [Related]  

  • 29. [Obtaining blood group test serums and initial plasma for the preparation of anti D-immunologlobulin for prevention of hemolytic disease of newborn by artificial immunization].
    Pilgrim G; Wicht U
    Z Gesamte Inn Med; 1971 Jan; 26(1):26-30. PubMed ID: 4997869
    [No Abstract]   [Full Text] [Related]  

  • 30. [Usefulness of extended serologic studies for avoiding of post-transfusion reactions].
    Wieczorek P; Lipowiec L
    Pol Tyg Lek; 1969 Feb; 24(7):246-7. PubMed ID: 4978152
    [No Abstract]   [Full Text] [Related]  

  • 31. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
    Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
    Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal anti-D reagents for blood group serology.
    Voak D; Sonneborn HH; Scott M
    Beitr Infusionsther; 1993; 31():140-6. PubMed ID: 7693243
    [No Abstract]   [Full Text] [Related]  

  • 33. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 34. [The prevention of rhesus antagonism].
    Dudok de Wit C
    Ned Tijdschr Geneeskd; 1967 Jun; 111(23):1062-3. PubMed ID: 4963071
    [No Abstract]   [Full Text] [Related]  

  • 35. Reactions of human anti-gamma-globulin factors with digested and urea-reduced gamma-chains.
    Lawrence TG; WIilliams RC
    J Immunol; 1966 Sep; 97(3):319-30. PubMed ID: 5297034
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of the studies on the use of anhydrous thermostable agglutination pastes for determination of ABO blood groups and Rh factors].
    Brodziński W; Wieczorek M; Zieleniak B
    Wiad Lek; 1969 May; 22(10):917-20. PubMed ID: 4977961
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary experiences with the prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993890
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increase of the activity of weak anti-Rh sera].
    Potkin-Posadskiĭ VA
    Lab Delo; 1973; 5():298-9. PubMed ID: 4129160
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evolution of anti-Rh antibodies idiotypy in a blood donor over 9 years].
    de Saint Martin J; Mukoyama H; Eyquem A
    C R Acad Hebd Seances Acad Sci D; 1978 Apr; 286(15):1183-6. PubMed ID: 78772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary experiences with ther prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.